Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine.

G. M. Daragan, T. Yu. Krushinska, D. O. Stepanskiy, I. V. Demchyshyna, I. P. Kolesnikova

Abstract


The analysis of measles and rubella morbidity, the state of their vaccination in Ukraine was carried out. Despite decades of preventive vaccination, there is a 5-6 years’ cyclicity of measles epidemic process at present time. Measles morbidity increased 46.8 times in 2017 in comparison with 2016. Elevated rates of rubella epidemic morbidity were registered in 2004 and 2011. There was decrease of routine measles and rubella immunization coverage in the period from 2009 to 2016. Critically low rates were noted in 2016 – 45.5% (vaccination) and 30.2% (revaccination). In spite of progress in the measles and rubella vaccination in 2017 (93.3% – vaccination and 90.7% – revaccination), Ukraine has not achieved the immunization coverage (≥95.0%) necessary to interrupt these pathogens circulation. The national laboratory and a network of regional ones, in-system of the Global Measles and Rubella Laboratory Network, were established in Ukraine to ensure high-quality performance of epidemiological surveillance. Genotyping of the clinical samples from Ukrainian measles and rubella patients is carried out in the WHO Regional Reference Laboratory (Luxembourg). Different genetic lines of the measles virus with prevalence of D8 genotype were indicated to circulate in Ukraine. The genotype B3 was also identified and the genotype D9 was isolated for the first time. In the furtherance of the goal of rubella and measles elimination in Ukraine, standard international approaches to clinical, laboratory and epide­miological diagnosis of cases, investigation of viruses transmission chains and detection of endemicity cases are in the course of implementation. Quality of the executing activities is assessed according to relevant standard indicators.

Keywords


vaccination; measles; rubella; elimination

References


Timchenko VN, Kaplina TA, Bulina OV, Leoni­cheva OA, Khakizimana ZhK, Timofeeva EV. [Actual problems of measles]. Pediatr. 2017;8(3):120-9. Russian. doi: 10.17816/PED83120-129

Chudna LM, Zadorozhna VI, Marychev IL, De­mchishina IV. [Vaccine and its impact on the incidence of infections managed by means of specific im­munization]. Profilaktychna medicina. 2013;1-2(20):3-10. Ukrainian.

Zherebtsova NY, Evdokimov VI, Shchibrik EV, Chebotareva TY, Mezenceva AL. [Characteristics of epi­demiology of measles in the modern stage in Belgorod region]. Nauchnye vedomosti BelGU. Seriya Meditsina. Farmatsiya. 2014;4(175):253-7. Russian.

MarichevIL, Brizhata SI, Protsap EI, Nekrasova LS, Svita VN,Vasheka LN.[State of measles vaccination inukraineand its impact on the epidemic process]. Pro­filaktychna medicina. 2012;3-4(19):3-7. Ukrainian.

Krasyuk LS, Bіlomerya TA, AlayevaOM, Kis­lyak ІІ, Alekseeva ІV, Myshko OV. [Trends of rubella’s epidemic process inukraine]. Profilaktychna medicina. 2012;2(18):57-59. Ukrainian.

MuldersMN, Serhan F, Goodson JL, Icenogle J, Johnson BW,RotaPA. Expansion of Surveillance for Vac­cine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Ru­bella Laboratory Network Platforms. The Journal of In­fectious Diseases. 2017;216(S1):324-330. doi: 10.1093/infdis/jix077

Furuse Y, Oshitani H. Global Transmission Dy­namics of Measles in the Measles Elimination Era. Viruses. 2017;9(4):82. doi: 10.3390/v9040082

Orenstein WA, Cairns L, Hinman A, Nkowane B, Olivé JM, Reingold AL. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: back­ground and summary. Vaccine. 2018;36(l):A35-A42. doi: 10.1016/j.vaccine.2017.10.065

O'Connor P, Jankovic D, Muscat M, Ben-Mamou M, Reef S, Papania M, Singh S, Kaloumenos T, Butler R, Datta S. Measles and rubella elimination in the WHO Re­gion forEurope: progress and challenges. Clin Micro­biol Infect. 2017;23(8):504-10. doi: 10.1016/j.cmi.2017.01.003

Goodson JL, Alexander JP, Linkins RW, Oren­stein WA. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach. Expert Rev Vaccines. 2017;16(12):1203-16. doi: 10.1080/14760584.2017.1393337

Santibanez S, Hübschen JM, Ben Mamou MC, Muscat M, Brown KE, Myers R, Donoso Mantke O, Zeichhardt H, Brockmann D, Shulga SV, Muller CP, O'Connor PM, Mulders MN, Mankertz A. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase. Clin Microbiol Infect. 2017;23(8):516-23. doi: 10.1016/j.cmi.2017.06.030

Coughlin MM, BeckAS, Bankamp B, RotaPA. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses. 2017;9(1):11. doi: 10.3390/v9010011

Plotkin SA, Reef SE. Rubella Vaccine. In: Plotkin SA,OrensteinWA, Offit PA, editors. Vaccines, fifth edi­tion.Philadelphia(PA), Saunders-Elsevier, 2008;735-1.

Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. Progress toward control of rubella and pre­vention of congenital rubella syndrome–worldwide, 2009. J Infect Dis. 2011;204(1);24–7. doi: 10.1093/infdis/jir155

Sniadack DH, Crowcroft NS, Durrheim DN, Rota PA. Roadmap to elimination- standard measles and rubella surveillance. Weekly epidemiological record. 2017;9/10(92):97-105.


GOST Style Citations


  1. Актуальные проблемы коревой инфекции / В.Н. Тимченко, Т.А. Каплина, О.В. Булина [и др.] // Педиатрия. – 2017. – Т. 8, № 3. – С. 120-129. doi: 10.17816/PED83120-129
  2. Вакцинопрофілактика та її вплив на рівень за­хворюваності інфекціями, що керуються засобами специфічної імунопрофілактики / Л.М. Чудна, В.І. За­дорожна, І. Л. Маричев, І. В. Демчишина // Профілак­тична медицина. – 2013. – № 1/2 (20) – С. 3-10.
  3. Особенности эпидемиологии кори на совре­менном этапе в Белгородской области / Н.Ю. Жереб­цова, В.И. Евдокимов, Е.В. Щибрик [и др.] // Научные ведомости БелГУ. Серия Медицина. Фармация. – 2014. – №4 (175). – С. 253-257.
  4. Стан вакцинопрофілактики кору в Україні та її вплив на епідемічний процес / И.Л. Маричев, С.И. Брижата, Е.И. Процап [та ін.] // Профілактична медицина – 2012. – № 3/4 (19). – С. 3-7.
  5. Тенденція розвитку епідемічного процесу краснухи в Україні / Л.С. Красюк, Т.А. Біломеря, О.М. Алаєва [та ін.] // Профілактична медицина. – 2012. – № 2 (18). – С.57-59.
  6. Expansion of Surveillance for Vaccine-preven­table Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms / M.N. Mulders, F. Serhan, J.L. Good­son [et al.] // J. Infectious Diseases. – 2017. – Vol. 216, Suppl. 1. – P. 324-330. doi: 10.1093/infdis/jix077
  7. Furuse Y. Global Transmission Dynamics of Measles in the Measles Elimination Era / Y. Furuse, H. Oshitani // Viruses. – 2017. – Vol. 9, N 4. – P. 82. doi: 10.3390/v9040082
  8. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: background and summary / W.A. Orenstein, L. Cairns, A. Hinman [et al.]. // Vac­cine. – 2018. – Vol. 11, N 36, Suppl. 1. – P. 35-42. doi: 10.1016/j.vaccine.2017.10.065
  9. Measles and rubella elimination in the WHO Re­gion for Europe: progress and challenges / P. O'Connor, D. Jankovic, M. Muscat [et al.] // Clin. Microbiol. Infect. – 2017. – Vol. 23, N 8. – P. 504-510. doi: 10.1016/j.cmi.2017.01.003
  10. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach / J.L. Goodson, J.P. Alexander, R.W. Linkins, W.A. Ore­nstein // Expert Rev. Vaccines. – 2017. – Vol. 16, N 12. – P. 1203-1216. doi: 10.1080/14760584.2017.1393337
  11. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the eli­mination phase / S. Santibanez, J. M. Hübschen, M.C. Ben Mamou [et al.] // Clin. Microbiol. Infect. – 2017. – Vol. 23, N 8. – P. 516-523. doi: 10.1016/j.cmi.2017.06.030
  12. Perspective on global measles epidemiology and control and the role of novel vaccination strategies / M.M. Coughlin, A.S. Beck, B. Bankamp, P.A. Rota // Viruses. – 2017. – Vol. 9, N 1. – Р. 11. doi: 10.3390/v9010011
  13. Plotkin S.A. Rubella Vaccine / S.A. Plotkin, S.E. Reef // Vaccines, fifth edition / S.A. Plotkin, W.A. Orenstein, P.A. Offit, editors. –Philadelphia: Saun­ders-Elsevier, 2008. – P. 735–771.
  14. Progress toward control of rubella and prevention of congenital rubella syndrome–worldwide, 2009 / S.E. Reef, P. Strebel, A. Dabbagh, M. Gacic-Dobo, S. Co­chi // J Infect Dis. – 2011. – Vol. 204, Suppl. 1. – P. 24-27. doi: 10.1093/infdis/jir155
  15. Roadmap to elimination- standard measles and rubella surveillance / D.H. Sniadack, N.S. Crowcroft, D.N. Durrheim, P.A. Rota // Weekly epidemiological Record. – 2017. – Vol. 9/10, N 92. – P. 97–105.




DOI: https://doi.org/10.26641/2307-0404.2018.1(part1).127206

Refbacks

  • There are currently no refbacks.